-
Something wrong with this record ?
CZecking heart failure in patients with advanced chronic kidney disease (Czech HF-CKD): Study protocol
J. Malik, A. Valerianova, SS. Pesickova, Z. Hruskova, V. Bednarova, P. Michalek, V. Polakovic, V. Tesar
Language English Country United States
Document type Clinical Trial Protocol, Journal Article
- MeSH
- Renal Insufficiency, Chronic * complications MeSH
- Kidney Failure, Chronic * diagnosis therapy complications MeSH
- Renal Dialysis adverse effects MeSH
- Humans MeSH
- Longitudinal Studies MeSH
- Observational Studies as Topic MeSH
- Heart Failure * diagnosis etiology therapy MeSH
- Water MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Clinical Trial Protocol MeSH
- Geographicals
- Czech Republic MeSH
BACKGROUND: Heart failure (HF) is a frequent cause of morbidity and mortality of end-stage kidney disease (ESKD) patients on hemodialysis. It is not easy to distinguish HF from water overload. The traditional HF definition has low sensitivity and specificity in this population. Moreover, many patients on hemodialysis have exercise limitations unrelated to HF. Therefore, we postulated two new HF definitions ((1) Modified definition of the Acute Dialysis Quality Improvement working group; (2) Hemodynamic definition based on the calculation of the effective cardiac output). We hypothesize that the newer definitions will better identify patients with higher number of endpoints and with more advanced structural heart disease. METHODS: Cohort, observational, longitudinal study with recording predefined endpoints. Patients (n = 300) treated by hemodialysis in six collaborating centers will be examined centrally in a tertiary cardiovascular center every 6-12 months lifelong or till kidney transplantation by detailed expert echocardiography with the calculation of cardiac output, arteriovenous dialysis fistula flow volume calculation, bio-impedance, and basic laboratory analysis including NTproBNP. Effective cardiac output will be measured as the difference between measured total cardiac output and arteriovenous fistula flow volume and systemic vascular resistance will be also assessed non-invasively. In case of water overload during examination, dry weight adjustment will be recommended, and the patient invited for another examination within 6 weeks. A composite major endpoint will consist of (1) Cardiovascular death; (2) HF worsening/new diagnosis of; (3) Non-fatal myocardial infarction or stroke. The two newer HF definitions will be compared with the traditional one in terms of time to major endpoint analysis. DISCUSSION: This trial will differ from others by: (1) detailed repeated hemodynamic assessment including arteriovenous access flow and (2) by careful assessment of adequate hydration to avoid confusion between HF and water overload.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24007855
- 003
- CZ-PrNML
- 005
- 20240423160334.0
- 007
- ta
- 008
- 240412s2024 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1177/11297298221099843 $2 doi
- 035 __
- $a (PubMed)35676802
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Malik, Jan $u Third Department of Internal Medicine, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000223863293 $7 xx0060338
- 245 10
- $a CZecking heart failure in patients with advanced chronic kidney disease (Czech HF-CKD): Study protocol / $c J. Malik, A. Valerianova, SS. Pesickova, Z. Hruskova, V. Bednarova, P. Michalek, V. Polakovic, V. Tesar
- 520 9_
- $a BACKGROUND: Heart failure (HF) is a frequent cause of morbidity and mortality of end-stage kidney disease (ESKD) patients on hemodialysis. It is not easy to distinguish HF from water overload. The traditional HF definition has low sensitivity and specificity in this population. Moreover, many patients on hemodialysis have exercise limitations unrelated to HF. Therefore, we postulated two new HF definitions ((1) Modified definition of the Acute Dialysis Quality Improvement working group; (2) Hemodynamic definition based on the calculation of the effective cardiac output). We hypothesize that the newer definitions will better identify patients with higher number of endpoints and with more advanced structural heart disease. METHODS: Cohort, observational, longitudinal study with recording predefined endpoints. Patients (n = 300) treated by hemodialysis in six collaborating centers will be examined centrally in a tertiary cardiovascular center every 6-12 months lifelong or till kidney transplantation by detailed expert echocardiography with the calculation of cardiac output, arteriovenous dialysis fistula flow volume calculation, bio-impedance, and basic laboratory analysis including NTproBNP. Effective cardiac output will be measured as the difference between measured total cardiac output and arteriovenous fistula flow volume and systemic vascular resistance will be also assessed non-invasively. In case of water overload during examination, dry weight adjustment will be recommended, and the patient invited for another examination within 6 weeks. A composite major endpoint will consist of (1) Cardiovascular death; (2) HF worsening/new diagnosis of; (3) Non-fatal myocardial infarction or stroke. The two newer HF definitions will be compared with the traditional one in terms of time to major endpoint analysis. DISCUSSION: This trial will differ from others by: (1) detailed repeated hemodynamic assessment including arteriovenous access flow and (2) by careful assessment of adequate hydration to avoid confusion between HF and water overload.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a srdeční selhání $x diagnóza $x etiologie $x terapie $7 D006333
- 650 12
- $a chronické selhání ledvin $x diagnóza $x terapie $x komplikace $7 D007676
- 650 _2
- $a longitudinální studie $7 D008137
- 650 _2
- $a dialýza ledvin $x škodlivé účinky $7 D006435
- 650 12
- $a chronická renální insuficience $x komplikace $7 D051436
- 650 _2
- $a voda $7 D014867
- 650 _2
- $a pozorovací studie jako téma $7 D064887
- 651 _2
- $a Česká republika $7 D018153
- 655 _2
- $a protokol klinické studie $7 D000078325
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Valerianova, Anna $u Third Department of Internal Medicine, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Pesickova, Satu Sinikka $u B. Braun Avitum, Dialysis Center Ohradni, Prague, Czech Republic $u Department of Nephrology, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Hruskova, Zdenka $u Department of Nephrology, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Bednarova, Vladimira $u Department of Nephrology, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Michalek, Pavel $u Department of Anaesthesiology and Intensive Medicine, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Polakovic, Vladimir $u Internal Department Strahov, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Tesar, Vladimir $u Department of Nephrology, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
- 773 0_
- $w MED00181745 $t The journal of vascular access $x 1724-6032 $g Roč. 25, č. 1 (2024), s. 294-302
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35676802 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240412 $b ABA008
- 991 __
- $a 20240423160330 $b ABA008
- 999 __
- $a ok $b bmc $g 2081706 $s 1217622
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 25 $c 1 $d 294-302 $e 20220608 $i 1724-6032 $m The journal of vascular access $n J Vasc Access $x MED00181745
- LZP __
- $a Pubmed-20240412